Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

LY518674

SKU: orb1218035

Description

LY518674 decreases triglycerides and increases HDL-C and is used for the treatment of atherosclerosis. LY518674 is an effective and selective PPARα antagonist (EC50: 42 nM for human PPARα).

Images & Validation

Key Properties

CAS Number425671-29-0
MW409.48
Purity>98% (HPLC)
FormulaC23H27N3O4
SMILESCC(C)(C(O)=O)Oc1ccc(CCCC(N2)=NN(Cc3ccc(C)cc3)C2=O)cc1
TargetPPAR
SolubilityDMSO:250 mg/mL (610.53 mM; Need ultrasonic)

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

LY-674

Similar Products

  • LY518674 [orb1308094]

    98.87% (May vary between batches)

    425671-29-0

    409.48

    C23H27N3O4

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

LY518674 (orb1218035)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Available Sizes

Select a size below

200 mg
500 mg
2 mg
$ 430.00
5 mg
$ 630.00
10 mg
$ 920.00
25 mg
$ 1,460.00
50 mg
$ 1,970.00
100 mg
$ 2,660.00